ENCell Co., Ltd. (KOSDAQ:456070)
South Korea · Delayed Price · Currency is KRW 5,420.00
-450.00 (-7.67%)
Oct 12, 2026, 3:30 PM KST
ENCell Market Cap
ENCell has a market cap or net worth of 59.78 billion as of October 12, 2026. It is the 31,106th most valuable company in the world and the 1,710th biggest in South Korea. Its market cap has decreased by 54.00% in one year.
Market Cap
59.78B
Enterprise Value
41.52B
Revenue
4.16B
Global Rank
Country Rank
#1,710 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 23, 2024, ENCell's market cap has decreased from 160.82B to 59.78B, a decrease of -62.83%. That is a compound annual growth rate of -37.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 59.78B | -69.88% |
| Dec 30, 2025 | 198.50B | 7.25% |
| Dec 30, 2024 | 185.09B | 15.09% |
| Aug 23, 2024 | 160.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeoImmuneTech | 187.06B |
| Anterogen.Co.,Ltd. | 162.00B |
| Genexine | 132.12B |
| MedPacto | 102.31B |
| Vaxcell-Bio Therapeutics | 101.05B |
| iNtRON Biotechnology | 87.89B |
| Prestige BioPharma | 71.63B |
| Amicogen | 69.47B |